99% Savings - Buy Urjas Massage Oil Just @1 Rs X
X Par is a prescription medicine that is available as a Tablet, Syrup. Secondary and off-label uses of X Par have also been mentioned below.
The correct dosage of X Par depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed X Par side effects, there are can be others also. These have been listed below. Such side effects of X Par normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that X Par has a Moderate effect for pregnant women and Moderate effect on lactating mothers. It is important to know if X Par has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the X Par related warnings section.
X Par is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Smoking Addiction are examples of such conditions. Other contraindications of X Par have been discussed in the sections ahead.
Besides this, X Par may also have severe interaction with some medicines. A complete list of these interactions is given below.
In addition to the above precautions for X Par, it is important to know that it is safe while driving, and is habit-forming.
X Par is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of X Par safe for pregnant women?
X Par may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take X Par again without your doctor's advice.
Is the use of X Par safe during breastfeeding?
Breastfeeding women may feel side effects of X Par. If you see any side effects, stop taking X Par immediately and talk to your doctor. Take X Par again, only after your doctor's advice.
What is the effect of X Par on the Kidneys?
Kidney can be affected by X Par. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of X Par on the Liver?
You may experience side effects on your liver after taking X Par. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of X Par on the Heart?
You may experience side effects on your heart after taking X Par. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
X Par should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take X Par unless your doctor advises you to do so -
Is this X Par habit forming or addictive?
Forming a habit of X Par has not been reported.
Interaction between Food and X Par
There isn't any research available on the side effects of taking X Par with food.
Interaction between Alcohol and X Par
Consuming X Par with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183